Nuclear medicine delivers exceptional sensitivity for early cancer detection and targeted treatment. Cleveland Clinic Abu Dhabi, for example, proves safe, painless, cost-effective treatment isn't aspirational — it's operational.

Radioactive iodine therapy for thyroid cancer

Thyroid cancer strikes women 3x more than men (peak: women 40-60, men 60-80).

Solution: One pill accumulates in the thyroid, destroys affected tissue—no surgery required.

Results:

Next step: Establish protocols within 90 days for eligible patients.

Y90 therapy for liver cancer

Yttrium-90 (Y90) injects radioactive material directly into the liver — targeting cancer while preserving healthy tissue.

Advantages:

Next step: Partner with interventional radiology to launch Y90 this quarter.

Related:Why your BCR-ABL results don't always add up

Build multidisciplinary teams

Integrate:

Next step: Convene weekly tumor boards for comprehensive care.

Invest in hot lab infrastructure

Requirements:

Next step: Audit capabilities and identify gaps within 60 days.

Leverage advanced tracers

Enable earlier diagnosis, more effective treatments, and better outcomes.

Next step: Adopt next-generation tracers for your highest-volume cancers.

Nuclear medicine delivers measurable outcomes today. Healthcare systems deploying these technologies now will lead cancer care.

Execute one action step this quarter. Lives depend on it.

Discover what you're missing. Read now on WHX Insights.